跳至主要内容
临床试验/EUCTR2022-001541-20-IS
EUCTR2022-001541-20-IS招募中1 期

Antibiotic exposure in early infancy and immune responses to vaccinations. - e-INFANT-2

未提供0 个研究点目标入组 200 人开始时间: 2024年5月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Term children born in Iceland in 2022-2023.
  • - Group A: Children delivered with elective caesarean section (their mothers received intra-operative antibiotics).
  • - Group B: Children delivered vaginally and their mothers received intra- partum antibiotics.
  • - Group C: Children delivered vaginally and received systemic antibiotics during the first week of life for at least 48 hours.
  • - Group D: Children born vaginally and did not receive systemic antibiotics during the first six months of life.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 200
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Immune suppression, allergy to vaccine components or any other contraindication to receiving the vaccines.

研究者

发起方
未提供

相似试验